Patents by Inventor Ronke Olabisi

Ronke Olabisi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11278597
    Abstract: Compositions of insulin-secreting cells and stem cells and methods for their use as well as use of insulin and stem cell products in wound healing and/or reducing scar and/or scab formation are provided.
    Type: Grant
    Filed: March 16, 2018
    Date of Patent: March 22, 2022
    Assignee: Rutgers, The State University of New Jersey
    Inventors: Ronke Olabisi, Ayesha Aijaz
  • Publication number: 20200085914
    Abstract: Compositions of insulin-secreting cells and stem cells and methods for their use as well as use of insulin and stem cell products in wound healing and/or reducing scar and/or scab formation are provided.
    Type: Application
    Filed: March 16, 2018
    Publication date: March 19, 2020
    Inventors: Ronke Olabisi, Ayesha Aijaz
  • Patent number: 8961999
    Abstract: A method and system to induce bone growth by locally delivering bone morphogenetic proteins (BMPs) to the target location for a prolonged period without invasive procedures are disclosed. The new bone growth is induced by delivering cells producing BMPs from transduced viral vectors to the target cite. In various embodiments, the cells are encapsulated in hydrogel microspheres that are non-degradable or degradable by enzymes produced during the bone formation process. Various embodiments may be used to induce spinal fusion or repair critical bone defects.
    Type: Grant
    Filed: December 1, 2010
    Date of Patent: February 24, 2015
    Assignees: Baylor College of Medicine, William Marsh Rice University
    Inventors: Alan R. Davis, Elizabeth A. Davis, Kevin Moran, Ronke Olabisi, Jennifer L. West, Christy Franco
  • Publication number: 20130017228
    Abstract: A method and system to induce bone growth by locally delivering bone morphogenetic proteins (BMPs) to the target location for a prolonged period without invasive procedures are disclosed. The new bone growth is induced by delivering cells producing BMPs from transduced viral vectors to the target cite. In various embodiments, the cells are encapsulated in hydrogel microspheres that are non-degradable or degradable by enzymes produced during the bone formation process. Various embodiments may be used to induce spinal fusion or repair critical bone defects.
    Type: Application
    Filed: December 1, 2010
    Publication date: January 17, 2013
    Applicant: Baylor College of Medicine
    Inventors: Alan R. Davis, Elizabeth A. Davis, Kevin Moran, Ronke Olabisi, Jennifer L. West, Christy Franco